Fortis Healthcare CFO Gagandeep Singh Bedi quits

NEW DELHI: Fortis Healthcare on Thursday said its Chief Financial Officer Gagandeep Singh Bedi has resigned citing personal reasons.

The Board of Directors of the company at its meeting held today have considered Bedi’s resignation from the services of the company, and accepted the same, with effect from September 30, 2018, Fortis Healthcare said in a filing to BSE.

The resignation is due to personal reasons, it added.

Shares of Fortis Healthcare today closed at Rs 148.70 per scrip on BSE, down 0.07 per cent from the previous close.

  • Related Posts

    A SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular Intercontinental

    Over 10, 000 Km afar Australia & India shrank into an OT New Delhi: The chemistry between best in class ‘made in India’ surgical robotic system SSi Mantra and unique…

    To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

    New ‘Bible’ of Nearly ‘Ideal’ Eating hit stands to become Instant Best Seller New Delhi: You are a veritable Hamlet when it comes to the question, to eat or not…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    IndiaAI, ICMR sign MoU to advance AI in healthcare

    IndiaAI, ICMR sign MoU to advance AI in healthcare

    Illegal drug manufacturing racket busted in Baddi area

    Illegal drug manufacturing racket busted in Baddi area

    US FDA and Telangana DCA bolster global pharma safety at second regulatory forum

    US FDA and Telangana DCA bolster global pharma safety at second regulatory forum

    Nishant as Health Minister, Bihar is all set to witness a New Dawn of Healthcare

    Nishant as Health Minister, Bihar is all set to witness a New Dawn of Healthcare

    Six Women Develop Serious Complications After C-Section

    Six Women Develop Serious Complications After C-Section

    Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected

    Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected